Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

YPrime Transforms Endocrinology and Autoimmune Trials through New Glucometer and eCOA Integrated Functionality

MALVERN, Pa., May 21, 2024 (GLOBE NEWSWIRE) -- YPrime, the leading pioneer in clinical trial technology, today announced the launch of its groundbreaking glucometer functionality designed to integrate seamlessly with its eCOA platform. This functionality, developed in close collaboration with patients living with diabetes, will transform endocrinology and autoimmune clinical trials by delivering a patient-centric, intuitive, and connected experience.

This release supports a wide selection of glucometer devices, enhancing YPrime's eCOA connected device strategy as the Company continues to expand device integrations to support multiple therapeutic areas. The new glucometer functionality addresses the unique needs of diabetes patients, sites, and clinical trial sponsors.

Key highlights include:

  • Effortless Pairing - Glucometer devices effortlessly pair with YPrime's patient-facing eCOA app, enabling connected secure data transfer and easing participant burden.
  • Intelligent Categorization - Patients can easily categorize glucose readings, such as fasting or post-meal, while continuous data monitoring provides valuable context for clinical trial data analysis.
  • Timely Alerts - High and low blood glucose alerts ensure timely notifications that promote symptom reporting and enhance patient compliance. 
  • Patient-Centric Design - Developed with extensive patient input, the glucometer feature offers an intuitive interface and seamless user experience.

"We are thrilled to introduce this revolutionary glucometer functionality, born out of our commitment to patient-focused innovation," said Mike Hughes, Chief Product Officer of YPrime. "By listening closely to patients living with diabetes and leveraging our expertise in eCOA, we have created a solution that truly empowers patients and unlocks new possibilities for endocrinology clinical trials and any indication requiring blood glucose logs."

Y-Prime, LLC

The YPrime Glucometer/eCOA functionality, developed in close collaboration with patients living with diabetes, delivers a patient-centric, intuitive, and connected experience.

YPrime's dedication to patient-centricity was evident throughout the development process of the glucometer functionality. The Company conducted in-depth interviews with patients and received valuable insights about their lived experiences to drive the feature's design and functionality. This collaborative approach ensures that the blood glucose monitoring functionality meets the real-world needs of its users. Automating data collection and transfer minimizes the burden on patients and site staff while ensuring data integrity. 

In related news, YPrime recently announced an eCOA assessment for Tender Swollen Joint Count (TSJC), increasing the accuracy and efficiency of clinical trials for diseases that affect the joints. Visit http://www.yprime.com/tsjc to learn how this user-centric functionality will reduce the burden for patients and site staff.

To learn more about how YPrime's eCOA enables industry leaders to solve for certainty or to request a demo, visit www.yprime.com/ecoa/.

About YPrime
At YPrime, we streamline the clinical trial journey with a configurable platform designed for speed, quality, and certainty. With 50% faster IRT startup times, up to 30% faster eCOA launch times, and quality standards 50% above the industry average, YPrime can help you solve for certainty. Discover how by visiting www.yprime.com or emailing marketing@yprime.com.

Media Contact        
Terry Rehm
Head of Thought Leadership and Public Relations, YPrime
trehm@yprime.com
862-288-0329


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.